DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy

NCT03369990 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Masseteric Hypertrophy

Interventions

DRUG: Botulinum toxin type A
DRUG: Placebos

Sponsor

Daewoong Pharmaceutical Co. LTD.